Medical News

RSS

BioMarin Pharmaceutical introduces Firdapse for LEMS in the E.U.

BioMarin Pharmaceutical Inc. announced today that Firdapse™ (3,4-diaminopyridine) is now commercially available in the European Union (E.U.) for the treatment of the rare autoimmune disease Lambert Eaton Myasthenic Syndrome (LEMS). Launching immediately in Germany and the UK, the company expects to subsequently launch Firdapse in all major European markets by the end of 2010.

19 Apr 2010

Immunomedics develops E1-L-thP1 protein complex for targeted delivery of siRNAs to diverse solid cancers

Immunomedics, Inc., a biopharmaceutical company focused on developing monoclonal antibodies to treat cancer and other serious diseases, today reported the development of a novel protein complex, designated as E1-L-thP1, for targeted delivery of small interfering ribonucleic acids (siRNAs) to diverse solid cancers.

19 Apr 2010

Ingen Technologies provides update on Proxy vote and plans up-list onto OTCBB

Ingen Technologies, Inc., is an ISO Certified and FDA Registered medical device manufacturer with an emerging new medical product line for the respiratory market worth an estimated $4 billion in the U.S., and $8 billion globally. The company sells their patented and proprietary Oxyview and SMART Nasal Cannula along with their most recent released INGEN Pulse Oximeter. Today the company announced Proxy results and growth plans.

19 Apr 2010

Affinion Security Center enhances BreachShield service

Affinion Security Center, a leading provider of identity theft protection services, today announced enhancements to its BreachShield(SM) service, aimed at preventing, detecting and resolving Identity Theft resulting from data breaches for companies at risk and the consumers who trust those organizations. The new enhancements are designed for all types of organizations that experience a breach and include benefits that help customers at risk for medical identity theft.

19 Apr 2010

The AFA and IntegraMed partner to provide innovative fertility education programs

Patients dealing with infertility face many uncertainties, but now there is one place to find a comprehensive guide to almost every aspect of infertility treatment.

19 Apr 2010

Biomarkers to help predict development of aggressive colorectal cancer discovered

Researchers at the University of Alabama at Birmingham (UAB) Department of Pathology have discovered a set of four biomarkers that will help predict which patients are more likely to develop aggressive colorectal cancer and which are not. The findings also shed light on the genetics that result in worse colorectal cancer-treatment outcomes for African-Americans, compared with Caucasians, the researchers said.

19 Apr 2010

PRA International expands clinical research operations to New Zealand

PRA International, a leading Clinical Research Organization, announces it has established a legal entity and hired staff in New Zealand, which will complement the firm's extensive network of Asia-Pacific operations and partnerships.

19 Apr 2010

Caliper Life Sciences introduces Quantum FX stand-alone microCT system for preclinical imaging

Caliper Life Sciences, Inc., a leading provider of tools and services for drug discovery, life sciences research and molecular diagnostics, today announced the Quantum FX, a stand-alone microCT system for preclinical imaging. Introduced at the American Association for Cancer Research Annual Meeting 2010, the Quantum FX is a low dose, microCT system that provides researchers with a 3-dimensional anatomical view of disease activity, tumor development and therapeutic response over multiple time points during the course of a study.

19 Apr 2010

Matrix Laboratories' ANDA for Didanosine Delayed-release Capsules receives FDA approval under PEPFAR

Mylan Inc. today announced that its subsidiary Matrix Laboratories Limited has received final approval from the U.S. Food and Drug Administration (FDA) under the President's Emergency Plan for AIDS Relief (PEPFAR) for its Abbreviated New Drug Application (ANDA) for Didanosine Delayed-release Capsules, 125 mg, 200 mg, 250 mg and 400 mg, the generic version of Bristol Myers Squibb's HIV treatment Videx® EC.

19 Apr 2010

FDA approves Sagent Pharmaceuticals' mesna injection for hemorrhagic cystitis

Sagent Pharmaceuticals, Inc., a privately held specialty pharmaceutical company, today announced the Company has received U.S. Food and Drug Administration (FDA) approval to market mesna injection (mesna), a prophylactic agent used to reduce the incidence of hemorrhagic cystitis caused by ifosfamide chemotherapy.

19 Apr 2010

Michigan medical equipment suppliers unhappy about Medicare competitive bidding

Crain's Detroit Business: A regulatory change by the Centers for Medicare and Medicaid Services "could put a crimp on hospital-based medical home product subsidiaries and hundreds of other Michigan-based vendors," an industry that has been growing.

19 Apr 2010

Alere director to analyze value of worksite health programs at 28th SALGBA conference

The importance of measuring productivity, short-term disability, workers' comp and job satisfaction when analyzing the value of worksite health programs will be the key focal points of a presentation by David Wolf, MBA, director of product management for Alere, at the 28th annual State and Local Government Benefits Association (SALGBA).

19 Apr 2010

2010 Driven to Quit Challenge: 11 tobacco-free Ontarians declared winners

Eleven newly tobacco-free Ontarians will be declared winners of the 2010 Driven to Quit Challenge next week. More than 28,800 showed their drive and pledged to quit their tobacco use for their chance to win a new Ford Escape hybrid, one of two $5,000 vacation getaways and $15,000 in MasterCard gift cards. Winners and their support buddies will be on site with guest speakers and their prizes, including the new hybrid vehicle.

19 Apr 2010

Valedictory Symposium to celebrate Professor David Taylor's contribution to Obstetrics and Gynaecology

Medical experts from across the UK are gathering at the University of Leicester on Friday 23rd April in a Valedictory Symposium to celebrate the work of Professor David Taylor.

19 Apr 2010

Weeklong, 60-mile breast cancer fundraising walk in Spain

For A Cause, has been organizing breast cancer fundraising walks since 2001. This Mother's Day, the unofficial start to the breast cancer walking season, tens of thousands of women will take to the streets to raise awareness and funds for breast cancer organizations.

19 Apr 2010

Study finds impact of free prescriptions on dispensing rates minimal

The overall impact of free prescriptions on dispensing rates in Wales has been minimal according to research conducted by academics at the University of Glamorgan in collaboration with colleagues at Cardiff and Bangor Universities.

19 Apr 2010

Héma-Québec to highlight vital role played by volunteers in maintaining collective blood supply

For this National Volunteer Week, with the theme "Volunteer for life", Héma-Québec would like to highlight the vital role played by community partners in maintaining the collective blood supply at a sufficient level.

19 Apr 2010

Pivotal preclinical data of YM BioSciences' CYT387 JAK1/2 inhibitor pre-published in Blood

YM BioSciences Inc., announced the pre-publication of pivotal preclinical data for CYT387, the company's highly selective and potent JAK1/2 inhibitor, currently in a Phase I/II trial for myelofibrosis.

19 Apr 2010

Experts to speak at international conference on autism

World renowned experts from Australia, the UK and the Ukraine are to speak at an international conference on autism, hosted at the University of Leicester by the organization jelibean.com, which provides help, advice and advocacy services to those on the autism spectrum, and those with AD/HD.

19 Apr 2010

SOKO Fitness reports 58% increase in third-quarter of fiscal 2010 revenues

SOKO Fitness & Spa Group, Inc., an operator of fitness centers and beauty salons and spas in Northeast China as well as suburban Beijing, today announced financial results for the third quarter and first nine months of fiscal 2010, ended February 28, 2010.

19 Apr 2010

Medical News

BioMarin Pharmaceutical introduces Firdapse for LEMS in the E.U.

Immunomedics develops E1-L-thP1 protein complex for targeted delivery of siRNAs to diverse solid cancers

Ingen Technologies provides update on Proxy vote and plans up-list onto OTCBB

Affinion Security Center enhances BreachShield service

The AFA and IntegraMed partner to provide innovative fertility education programs

Biomarkers to help predict development of aggressive colorectal cancer discovered

PRA International expands clinical research operations to New Zealand

Caliper Life Sciences introduces Quantum FX stand-alone microCT system for preclinical imaging

Matrix Laboratories' ANDA for Didanosine Delayed-release Capsules receives FDA approval under PEPFAR

FDA approves Sagent Pharmaceuticals' mesna injection for hemorrhagic cystitis

Michigan medical equipment suppliers unhappy about Medicare competitive bidding

Alere director to analyze value of worksite health programs at 28th SALGBA conference

2010 Driven to Quit Challenge: 11 tobacco-free Ontarians declared winners

Valedictory Symposium to celebrate Professor David Taylor's contribution to Obstetrics and Gynaecology

Weeklong, 60-mile breast cancer fundraising walk in Spain

Study finds impact of free prescriptions on dispensing rates minimal

Héma-Québec to highlight vital role played by volunteers in maintaining collective blood supply

Pivotal preclinical data of YM BioSciences' CYT387 JAK1/2 inhibitor pre-published in Blood

Experts to speak at international conference on autism

SOKO Fitness reports 58% increase in third-quarter of fiscal 2010 revenues

Evolving spectrophotometry for modern biopharma workflows

Scaling B-cell cloning workflows for antibody development

Fluidics in Modern Healthcare & Medical Device Innovation

Latest News